Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 22, 2022 - Issue 12: Biological therapies for psoriasis
Submit an article Journal homepage
370
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Guselkumab for the treatment of psoriasis: a 60-week real-life multicenter retrospective experience

Federico Bardazzia Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum, University of Bologna, Bologna, Italy;b Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna
,
Filippo Viviania Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum, University of Bologna, Bologna, Italy;b Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, BolognaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3606-292X
ORCID Icon,
Yuri Merlia Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum, University of Bologna, Bologna, Italy;b Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna
,
Vito Di Lerniac Dermatology Unit, Arcispedale Santa Maria Nuova-IRCCS, Reggio Emilia, Italy
,
Francesca Peccerilloc Dermatology Unit, Arcispedale Santa Maria Nuova-IRCCS, Reggio Emilia, Italy
,
Andrea Contid Department of Surgical, Medical, Dental and Morphological Sciences related to Transplant, Oncology and Regenerative Medicine, Dermatology Unit, University of Modena and Reggio Emilia, Modena, Italy
,
Claudia Lasagnid Department of Surgical, Medical, Dental and Morphological Sciences related to Transplant, Oncology and Regenerative Medicine, Dermatology Unit, University of Modena and Reggio Emilia, Modena, Italy
,
Michela Tabanellie Dermatology Unit, AUSL della Romagna, Ravenna, Italy
,
Simone D’Adamioe Dermatology Unit, AUSL della Romagna, Ravenna, Italy
,
Sergio Di Nuzzof Dermatology, Department of Medicine and Surgery, University of Parma, Parma, Italy
,
Chiara Cortellazzif Dermatology, Department of Medicine and Surgery, University of Parma, Parma, Italy
&
Federica Filippia Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum, University of Bologna, Bologna, Italy;b Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, BolognaORCID Iconhttps://orcid.org/0000-0001-8173-4257
ORCID Icon show all
Pages 1561-1566 | Received 07 Feb 2022, Accepted 06 Apr 2022, Published online: 13 Apr 2022

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Marco Galluzzo, Lorenzo Marcelli, Laura Vellucci, Claudia Paganini, Virginia Maffei, Lorenzo Tofani, Alfredo Belcastro, Luca Bianchi & Marina Talamonti. (2023) Guselkumab for treatment of moderate-to-severe plaque psoriasis: real-life effectiveness and drug-survival for up to 148 weeks. Expert Opinion on Biological Therapy 23:4, pages 371-381.
Read now
Matteo Megna, Luca Potestio, Gabriella Fabbrocini & Angelo Ruggiero. (2022) Long-Term Efficacy and Safety of Guselkumab for Moderate to Severe Psoriasis: A 3-Year Real-Life Retrospective Study. Psoriasis: Targets and Therapy 12, pages 205-212.
Read now
Angelo Ruggiero, Vincenzo Picone, Fabrizio Martora, Gabriella Fabbrocini & Matteo Megna. (2022) Guselkumab, Risankizumab, and Tildrakizumab in the Management of Psoriasis: A Review of the Real-World Evidence. Clinical, Cosmetic and Investigational Dermatology 15, pages 1649-1658.
Read now
Marco Galluzzo, Marina Talamonti, Nicoletta Bernardini, Andrea Chiricozzi, Clara De Simone, Claudio Bonifati, Pierluigi Bruni, Federico Diotallevi, Maria Esposito, Dario Graceffa, Katharina Hansel, Francesco Loconsole, Gaia Moretta, Cristina Mugheddu, Manuela Papini, Antonio Richetta, Nevena Skroza, Laura Atzori, Maria Concetta Fargnoli, Severino Persechino, Annamaria Offidani, Luca Stingeni, Ketty Peris, Concetta Potenza & Luca Bianchi. (2022) Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year. Expert Opinion on Biological Therapy 22:12, pages 1585-1592.
Read now

Articles from other publishers (1)

Jing Yang, Kun hu, Xingyu Li, Jingjin Hu, Minjia Tan, Mi Zhang, Yehong Kuang, Chengzhi Lv & Junchen Chen. (2022) Effectiveness and Safety of Guselkumab for the Treatment of Psoriasis in Real-World Settings at 52 weeks: A Retrospective, Observational, Multicenter Study from China. Dermatology and Therapy 13:2, pages 477-485.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.